The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 22, 2020

Filed:

Jan. 09, 2017
Applicants:

The University of Connecticut, Farmington, CT (US);

United States of America As Represented BY the Department of Veterans Affairs, Syracuse, NY (US);

Inventors:

Dennis Wright, Storrs, CT (US);

Amy C. Anderson;

Eric Scocchera, Mansfield Center, CT (US);

Narendran Gummudipundi Dayanandan, Mansfield Center, CT (US);

Santosh Keshipeddy, Hamden, CT (US);

Stephanie Reeve, Manchester, CT (US);

Michael N. Lombardo, Manchester, CT (US);

Michael Henry Cynamon, Dewitt, NY (US);

Assignee:

UNIVERSITY OF CONNECTICUT, Farmington, CT (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 405/06 (2006.01); C07D 405/14 (2006.01); C07D 239/02 (2006.01); C07D 239/48 (2006.01); C07D 239/49 (2006.01); C07D 403/10 (2006.01); A61P 31/04 (2006.01); A61P 31/06 (2006.01); A61K 31/505 (2006.01); A61K 31/506 (2006.01);
U.S. Cl.
CPC ...
C07D 239/49 (2013.01); A61K 31/505 (2013.01); A61K 31/506 (2013.01); A61P 31/04 (2018.01); A61P 31/06 (2018.01); C07D 239/48 (2013.01); C07D 403/10 (2013.01); C07D 405/06 (2013.01); C07D 405/14 (2013.01);
Abstract

The disclosure provides compounds of the formula I and the pharmaceutically acceptable salts thereof. The variables, e.g. R, R, R, R, A, B, J, V, W, M, J and Ar are defined herein. The disclosure also provides pharmaceutical compositions comprising a compound or salt of formula I and a pharmaceutically acceptable carrier, methods of inhibiting dihydrofolate reductase (DHFR) in vitro or in vivo with a compound or salt of formula I, and methods of treating a bacterial infections, fungal infections, and protozoal infections with a compound or salt of formula I. A compound or salt of formula I can be the first and only active ingredient used in a pharmaceutical composition or method of this disclosure or may be combined with one or more additional active ingredients that are not compounds or salts of formula I.


Find Patent Forward Citations

Loading…